Vitamin D and Inflammatory Bowel Disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Inflammatory bowel disease (IBD) is a chronic intestinal inflammation that occurs because of uncontrolled immune responses to commensal microflora in the gut and is estimated to affect over 1 million Americans. The factors that predispose individuals are not completely understood. Both genetics and environmental factors play a role in the development of IBD. IBD is more prevalent in northern than southern regions of North America and Europe. Vitamin D is an important regulator of the immune system; patients with IBD are frequently vitamin D deficient and vitamin D-deficient animals have increased susceptibility to IBD. The autoimmune response in IBD is suppressed by active metabolites of vitamin D. There is no cure for IBD. Immunosuppressive drugs are used to suppress the intestinal inflammation in patients with IBD, but these drugs are extremely expensive and increase the risk of infection and cancer. Vitamin D supplementation could be a safe and effective adjunct to the therapies available to treat or prevent IBD.

Original languageEnglish (US)
Title of host publicationHealth, Disease and Therapeutics
PublisherElsevier Inc.
Pages1025-1036
Number of pages12
Volume2
ISBN (Electronic)9780128099650
ISBN (Print)9780128099643
DOIs
StatePublished - Dec 14 2017

Fingerprint

inflammatory bowel disease
vitamin D
Inflammatory Bowel Diseases
Vitamin D
inflammation
Inflammation
immunosuppressive agents
drugs
autoimmunity
Immune system
Immunosuppressive Agents
Metabolites
North America
Autoimmunity
intestinal microorganisms
Pharmaceutical Preparations
immune system
Immune System
Animals
immune response

All Science Journal Classification (ASJC) codes

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Cantorna, M. T-A., & Bruce, D. (2017). Vitamin D and Inflammatory Bowel Disease. In Health, Disease and Therapeutics (Vol. 2, pp. 1025-1036). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-809963-6.00108-5
Cantorna, Margherita Teresa-Anna ; Bruce, Danny. / Vitamin D and Inflammatory Bowel Disease. Health, Disease and Therapeutics. Vol. 2 Elsevier Inc., 2017. pp. 1025-1036
@inbook{d8a1310afeea4a3f9c78d6b17dcc94b9,
title = "Vitamin D and Inflammatory Bowel Disease",
abstract = "Inflammatory bowel disease (IBD) is a chronic intestinal inflammation that occurs because of uncontrolled immune responses to commensal microflora in the gut and is estimated to affect over 1 million Americans. The factors that predispose individuals are not completely understood. Both genetics and environmental factors play a role in the development of IBD. IBD is more prevalent in northern than southern regions of North America and Europe. Vitamin D is an important regulator of the immune system; patients with IBD are frequently vitamin D deficient and vitamin D-deficient animals have increased susceptibility to IBD. The autoimmune response in IBD is suppressed by active metabolites of vitamin D. There is no cure for IBD. Immunosuppressive drugs are used to suppress the intestinal inflammation in patients with IBD, but these drugs are extremely expensive and increase the risk of infection and cancer. Vitamin D supplementation could be a safe and effective adjunct to the therapies available to treat or prevent IBD.",
author = "Cantorna, {Margherita Teresa-Anna} and Danny Bruce",
year = "2017",
month = "12",
day = "14",
doi = "10.1016/B978-0-12-809963-6.00108-5",
language = "English (US)",
isbn = "9780128099643",
volume = "2",
pages = "1025--1036",
booktitle = "Health, Disease and Therapeutics",
publisher = "Elsevier Inc.",
address = "United States",

}

Cantorna, MT-A & Bruce, D 2017, Vitamin D and Inflammatory Bowel Disease. in Health, Disease and Therapeutics. vol. 2, Elsevier Inc., pp. 1025-1036. https://doi.org/10.1016/B978-0-12-809963-6.00108-5

Vitamin D and Inflammatory Bowel Disease. / Cantorna, Margherita Teresa-Anna; Bruce, Danny.

Health, Disease and Therapeutics. Vol. 2 Elsevier Inc., 2017. p. 1025-1036.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Vitamin D and Inflammatory Bowel Disease

AU - Cantorna, Margherita Teresa-Anna

AU - Bruce, Danny

PY - 2017/12/14

Y1 - 2017/12/14

N2 - Inflammatory bowel disease (IBD) is a chronic intestinal inflammation that occurs because of uncontrolled immune responses to commensal microflora in the gut and is estimated to affect over 1 million Americans. The factors that predispose individuals are not completely understood. Both genetics and environmental factors play a role in the development of IBD. IBD is more prevalent in northern than southern regions of North America and Europe. Vitamin D is an important regulator of the immune system; patients with IBD are frequently vitamin D deficient and vitamin D-deficient animals have increased susceptibility to IBD. The autoimmune response in IBD is suppressed by active metabolites of vitamin D. There is no cure for IBD. Immunosuppressive drugs are used to suppress the intestinal inflammation in patients with IBD, but these drugs are extremely expensive and increase the risk of infection and cancer. Vitamin D supplementation could be a safe and effective adjunct to the therapies available to treat or prevent IBD.

AB - Inflammatory bowel disease (IBD) is a chronic intestinal inflammation that occurs because of uncontrolled immune responses to commensal microflora in the gut and is estimated to affect over 1 million Americans. The factors that predispose individuals are not completely understood. Both genetics and environmental factors play a role in the development of IBD. IBD is more prevalent in northern than southern regions of North America and Europe. Vitamin D is an important regulator of the immune system; patients with IBD are frequently vitamin D deficient and vitamin D-deficient animals have increased susceptibility to IBD. The autoimmune response in IBD is suppressed by active metabolites of vitamin D. There is no cure for IBD. Immunosuppressive drugs are used to suppress the intestinal inflammation in patients with IBD, but these drugs are extremely expensive and increase the risk of infection and cancer. Vitamin D supplementation could be a safe and effective adjunct to the therapies available to treat or prevent IBD.

UR - http://www.scopus.com/inward/record.url?scp=85054945377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054945377&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-809963-6.00108-5

DO - 10.1016/B978-0-12-809963-6.00108-5

M3 - Chapter

AN - SCOPUS:85054945377

SN - 9780128099643

VL - 2

SP - 1025

EP - 1036

BT - Health, Disease and Therapeutics

PB - Elsevier Inc.

ER -

Cantorna MT-A, Bruce D. Vitamin D and Inflammatory Bowel Disease. In Health, Disease and Therapeutics. Vol. 2. Elsevier Inc. 2017. p. 1025-1036 https://doi.org/10.1016/B978-0-12-809963-6.00108-5